Related Experiment Videos
Design and evaluation of cyclodextrin-based drug formulation.
1Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. uekama@gpo.kumamoto-u.ac.jp
Chemical & Pharmaceutical Bulletin
|August 12, 2004
Summary
Cyclodextrins (CyDs) improve drug formulations by enhancing absorption, controlling release, and enabling targeted delivery. These versatile compounds alleviate undesirable drug properties through complexation or conjugation.
Area of Science:
- Pharmaceutical Science
- Drug Delivery Systems
- Supramolecular Chemistry
Background:
- Cyclodextrins (CyDs) are versatile pharmaceutical excipients with hydrophilic, hydrophobic, and ionic derivatives.
- Their multi-functional characteristics and bioadaptability allow for the improvement of drug molecules' undesirable properties.
- CyDs achieve this through the formation of inclusion complexes or CyD/drug conjugates.
Purpose of the Study:
- To review the current applications of cyclodextrins in drug formulation design and evaluation.
- To highlight the role of CyDs in enhancing drug absorption across biological barriers.
- To discuss the ability of CyDs to control drug release profiles and facilitate targeted drug delivery.
Main Methods:
- Literature review of cyclodextrin applications in pharmaceutical formulations.
- Analysis of studies focusing on CyD-mediated drug absorption enhancement.
- Evaluation of research on CyD-based controlled and targeted drug delivery systems.
Main Results:
- Cyclodextrins effectively enhance drug absorption across various biological barriers.
- CyD-based formulations demonstrate significant control over drug release rates and time profiles.
- Targeted drug delivery is achievable using specific cyclodextrin derivatives and strategies.
Conclusions:
- Cyclodextrins are valuable tools in pharmaceutical formulation for improving drug efficacy and patient compliance.
- The application of cyclodextrins in drug delivery is expanding, offering solutions for bioavailability and targeting challenges.
- Further research into novel cyclodextrin derivatives and formulations will continue to advance drug delivery technologies.